Richard Cappetta, President and CEO of MicroVention, Inc., said: "The HEAT trial is intended to provide evidence that our second-generation hydrogel coil technologies provide superior long-term ...

Please provide your email address to receive an email when new articles are posted on . Patients with intracranial aneurysms who underwent embolization with second-generation hydrogel-coated coils ...

MIAMI & ALISO VIEJO, Calif.--(BUSINESS WIRE)-- MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, is celebrating a decade of legacy innovation ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced that the SOFIA™ EX 5F 115 cm Intracranial ...

MicroVention Inc., an Aliso Viejo-based startup medical device maker, has nabbed $10 million in an extension of its fourth round of venture funding. The new investment brings MicroVention’s total ...

US-based neuroendovascular device company MicroVention has announced a court settlement against three former members of staff accused of misappropriating trade secrets about the company’s embolic ...

DUBLIN, Oct. 19, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/j87v3m/global) has announced the addition of the "Global ...

Research and Markets has announced the addition of the "Global Neuroendovascular Coil and Non-Coil Devices Market - Growth, Trends and Forecasts (2016 - 2021)" report to their offering. The research ...

MicroVention Inc., Orange County’s sixth-largest medical device maker with about 1,150 local workers, has expansion plans in its hometown of Aliso Viejo, with a sizeable new lease recently signed just ...